Log in

Articles of Interest


Assessment of Changes in the Geographical Distribution of Opioid- Related Mortality Across the United States by Opioid Type, 1999-2016      read more


Deprescribing: A simple method
for reducing polypharmacy

Polypharmacy brings with it increased risks for adverse drug events and reduced functional capacity. This 4-step
plan will help you safely deprescribe in older adults.
read more

New Hampshire House passes bill allowing pharmacists to prescribe contraceptives read more


The Deadly Counterfeit Drug Trade
Thrives in New Hampshire
. read more


Social Media Sites: The New Wild West  for Illegal Online Pharmacies  read more


 A Prescriber’s Guide to the New Medicare Part D Opioid Overutilization Policy for 2019  read more


National Institute of Health 2018 New Hampshire Report   read more

A message from the NH Department of Health and Human Services (DHHS)

NH Hepatitis A Outbreak - read more


Pharmacy Organizations Support National Standards for Technician Education - Read More


 Effective January 1, 2019

  SB 376  requires all pharmacies in New Hampshire that sell over the counter pseudoephedrine (PSE)/ephedrine (EPH) products to participate in NPLEx, which provides real time PSE electronic tracking in accordance with the Combat Methamphetamine Epidemic Act (CMEA).NPLEx is provided FREE of charge.    Click Here for full info  


FDA declares youth vaping epidemic, announces investigation, new enforcement.   read more


Blood Pressure Recall expands again to include losartan  read more


APhA Continues to Fight for Pharmacists’ Services in Federal Legislation

Even though many of you answered APhA’s calls for support and outreach, the opioid bill passed by Congress and signed into law by President Trump did not include any Medicare Part B coverage of pharmacists’ opioid-related services. During the development of this year’s opioid legislative package, congressional leadership made it clear that they would exclude measures having a significant budget implication and therefore, the potential cost or score had been the major barrier to the inclusion of pharmacists’ services language. While we are admittedly extremely disappointed, our work was not in vain. There is a better awareness and understanding in Congress and federal agencies regarding the broad range of services—including those related to pain management and substance use disorders— that pharmacists can provide, and more appreciation for their value.

APhA wants to reiterate our thanks and appreciation to the thousands of you who reached out to your legislators asking for the passage of H.R. 592/S. 109, the Pharmacy and Medically Underserved Areas Enhancement Act and for related language to be added in opioid legislation.

The lack of congressional passage is not indicative of the value of our profession’s efforts nor of APhA’s efforts to inform legislators and the Administration of the importance of covering pharmacists’ services. The estimated cost of expanding patient access to pharmacists’ services has always been a concern of Members of Congress.



New Hampshire Pharmacists Association 

373 South Willow Street  D1-1, Suite 165

Manchester, NH 03103

Email: info@nhpharmacists.net

NHPA Mission Statement

The mission of the New Hampshire Pharmacists Association is to promote, enhance, and advance pharmacy practice, in the State of New Hampshire by advocating for the professional interests of pharmacists, pharmacy technicians, student pharmacists, and ancillary pharmacy personnel as well as to advocate for the health and welfare of the general public.

Search Our Website

Powered by Wild Apricot Membership Software
} catch(err) {}